Wheeler Bio key facts
as of Oct 2026- Developer of a biomanufacturing service intended to accelerate the translation of therapeutic innovations into clinical impact.
- Wheeler Bio is valued at approximately $83.0M as of Oct 2026 (last reported valuation).
- It has raised $81.0M across 3 recorded rounds; the latest was Early Stage VC ($23.1M) in Mar 2025.
- Notable investors include Floating Point, Carnrite Ventures, Echo Investment Capital, Presbyterian Health Foundation, ATUM (Biotechnology) — 14 tracked in total.
- Wheeler Bio has filed 3 Form Ds with the SEC since 2021, most recently Apr 2025 ($23.1M sold to 18 investors).
- Status: Privately Held (backing).
Wheeler Bio's last reported valuation, May 2023. Nothing priced has surfaced since.
- ·The complete investor list: 14 names
- ·Watch Wheeler Bio: the Monday email on marks, rounds and moves
Wheeler Bio funding rounds
3 roundsWho backs Wheeler Bio
14+Wheeler Bio valuation
Wheeler Bio's last reported valuation was $83 million in May 2023. No priced round, secondary trade or fund mark has surfaced since.
How much has Wheeler Bio raised?
Wheeler Bio has raised $81 million across 3 recorded rounds since 2021. The largest was a $23.2 million early-stage round in Sep 2022; the most recent was a $23.1 million early-stage round in Mar 2025.
Wheeler Bio has filed 3 Form Ds with the SEC since 2021, most recently in Apr 2025 ($23.1 million sold to 18 investors).
Wheeler Bio investors
14 investors are on record for Wheeler Bio, including Floating Point, Carnrite Ventures, Echo Investment Capital and Presbyterian Health Foundation. The early-stage round in Mar 2025 drew 18 investors.
About Wheeler Bio
Developer of a biomanufacturing service intended to accelerate the translation of therapeutic innovations into clinical impact. The company services avoid the critical gaps between discovery and early development and provide access to rapid, quality biomanufacturing that aligns with different stages of development, enabling pharmaceutical companies to streamline their drug development processes.
- Sector
- Healthcare
- HQ
- Oklahoma City, OK, United States
- Founded
- 2020
- Employees
- 74
- Website
- wheelerbio.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.